Back
Ultragenyx Pharmaceutical Stock Price Chart

Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
$36.61
Seasonality Move:
8.27%
7 Day Trial
ALL ACCESS PASS
$
7

Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
The current trend is relatively stagnant and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.41 | Buy |
20-day SMA: | 35.45 | Buy |
50-day SMA: | 35.84 | Buy |
200-day SMA: | 45.24 | Sell |
8-day EMA: | 35.75 | Buy |
20-day EMA: | 35.77 | Buy |
50-day EMA: | 36.67 | Sell |
200-day EMA: | 41.7 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 53.3 | Buy |
Chaikin Money Flow: | 69387 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.45 - 37.55) | Buy |
Bollinger Bands (100): | (35.28 - 42.6) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 36.61 while RARE 8-day simple moving average is 35.41, which is a Buy signal.
-
The stock price of RARE is 36.61 while Ultragenyx Pharmaceutical 20-day SMA is 35.45, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 35.84 while RARE share price is 36.61, making it a Buy technically.
-
RARE stock price is 36.61 and Ultragenyx Pharmaceutical 200-day simple moving average is 45.24, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $36.61. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.5B
Price in USD:
36.61
Share Volume:
759.2K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
29.59
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 36.61 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 36.61 while RARE 8-day exponential moving average is 35.75, which is a Buy signal.
-
The stock price of RARE is 36.61 while Ultragenyx Pharmaceutical 20-day EMA is 35.77, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 36.67 while RARE share price is 36.61, making it a Sell technically.
-
RARE stock price is 36.61 and Ultragenyx Pharmaceutical 200-day simple moving average is 41.70, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.37 per share, an increase this year of $0.84 per share, and an increase next year of $1.76 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Ultragenyx Pharmaceutical is a Sell
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 53.3, which suggest Ultragenyx Pharmaceutical is overbought
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (34.45 - 37.55), which suggest Ultragenyx Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (35.28 - 42.6), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.